Chronic pain and mobility outcomes following primary hip arthroplasty. A comparison of intravenous morphine with lumbar plexus levobupivacaine. - Chronic pain and mobility outcomes following primary hip arthroplasty

Belfast Health and Social Care Trust0 个研究点开始时间: 2009年9月17日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•Inclusion criteria
•i)ASA class I-III
•American Society of Anesthesiologists classification system for all patients undergoing anaesthesia
•Class I - normal healthy patient
•Class II - patient with mild systemic disease
•Class III - patient with severe systemic disease
•ii)Age > 18yr < 85yr
•iii)Patient able to give written, informed consent
•iv) Patient requiring primary hip arthroplasty
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Exclusion criteria
•i)History of dementia
•ii)ASA class IV-V
•Class IV - patient with severe systemic disease which is a constant threat to life
•Class V - patient who is not expected to survive without the operation
•iii)History of allergy to any of the medications used in the study.
•iv)Inflammatory polyarthritis of a severity likely to compromise postoperative mobility
•v)Contraindication to regional anaesthesia
•vi)Patients suffering from severe hypotension such as cardiogenic or hypovolaemic shock or with a serious cardiac arrhythmia

发起方